Skip to main content
19 May 2024
Last updated:
Friday 10 May 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Case study - the merits of adaptive trial design
Read more
Seismic shift ahead for drug pricing
Read more
Drugs for orphan diseases are no longer rare
Read more
Versant Ventures eyes start-ups in Europe
Read more
JP Morgan forum ends on a positive note
Read more
Market Commentary: How risky are European biotechs?
Read more
Cheap capital gives rise to integrated pharma R&D
Read more
Commentary: Thought disruption in R&D discovery
Read more
Market Analysis: The outlook for European pharma
Read more
New risk capital for European companies
Read more
Pagination
First page
« First
Previous page
‹‹
…
Page
10
Page
11
Page
12
Page
13
Current page
14
Page
15
Page
16
Page
17
Page
18
…
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form